AUS
NZ
UK
CA
USA
IND
Highlights:
Optiscan (ASX:OIL) unveils InForm, a cutting-edge digital pathology device designed to enhance diagnostic efficiency.
InForm delivers real-time digital imaging, transforming pathology workflows and supporting faster, more precise medical decisions.
The global implementation of InForm may improve diagnostic accessibility and optimize healthcare outcomes.
The medical imaging sector continues to evolve, with pathology now embracing digital transformation. Optiscan (ASX:OIL), a Melbourne-based company, has introduced InForm, an advanced microscopic imaging device designed to digitize and streamline pathology workflows. By offering real-time digital insights, InForm aims to enhance diagnostic accuracy and efficiency from the initial tissue sample to the final report.
Collaboration Driving Innovation
Developed in partnership with industrial design firm Design + Industry in Melbourne, InForm represents a significant leap forward in digital pathology. The device enables real-time digital conversion of pathology processes, allowing medical professionals to make well-informed decisions with greater speed and accuracy. By eliminating traditional slide-based methods, InForm supports a fully digital workflow that enhances diagnostic efficiency.
Transforming Traditional Practices
Unlike radiology and other diagnostic fields that have already transitioned to digital formats, pathology has remained largely dependent on manual procedures. InForm addresses this gap by replacing physical slides with a streamlined digital system. This shift is expected to improve the speed and accuracy of pathology assessments, making workflows more efficient and reducing the reliance on time-consuming manual techniques.
Enhancing Patient-Centric Care
The integration of real-time digital imaging into pathology aims to improve patient outcomes by reducing the time required for diagnoses. Faster access to pathology results allows for quicker medical interventions, improving overall patient care. The digital-first approach of InForm aligns with precision medicine, supporting more personalized and effective treatment strategies.
Expanding Global Reach
The demand for advanced pathology solutions continues to grow, and InForm is designed to be used across various clinical settings. From operating rooms requiring immediate sample analysis to laboratory environments focused on routine assessments, the device supports diverse applications. Its user-friendly design ensures seamless adoption, benefiting healthcare institutions worldwide.
Seamless Integration with Existing Systems
InForm is designed to be compatible with DICOM and PACS, facilitating smooth integration into hospital and laboratory infrastructures. Additionally, the upcoming launch of Optiscan’s cloud-based telepathology platform in the near future is expected to enhance global accessibility. Remote consultations and expert collaborations may become more efficient, helping address the worldwide shortage of pathologists while fostering knowledge sharing across regions.
This article was developed in collaboration with Optiscan, a Stockhead advertiser at the time of publishing. It does not provide financial guidance; independent professional advice should be sought for financial decisions.
